These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31808835)

  • 1. What we have learned about direct oral anticoagulant reversal.
    Siegal DM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):198-203. PubMed ID: 31808835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.
    Gómez-Outes A; Alcubilla P; Calvo-Rojas G; Terleira-Fernández AI; Suárez-Gea ML; Lecumberri R; Vargas-Castrillón E
    J Am Coll Cardiol; 2021 Jun; 77(24):2987-3001. PubMed ID: 34140101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal strategies in patients treated with direct oral anticoagulants.
    Gressenberger P
    Vasa; 2019 Aug; 48(5):389-392. PubMed ID: 30719950
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based Management of Major Bleeding in Patients Receiving Direct Oral Anticoagulants: An Updated Narrative Review on the Role of Specific Reversal Agents.
    Al Aseri Z; AlGahtani FH; Bakheet MF; Al-Jedai AH; Almubrik S
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231202655. PubMed ID: 37872658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversal agents for severe bleeding associated with direct oral anticoagulants].
    Giubilato S; Lucà F; Di Fusco SA; Amico F; Colivicchi F; Gulizia MM
    G Ital Cardiol (Rome); 2022 Oct; 23(10):734-745. PubMed ID: 36169124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of direct oral anticoagulants: a practical approach.
    Shih AW; Crowther MA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):612-619. PubMed ID: 27913536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.
    Crawley RM; Anderson RL
    Drugs; 2020 Sep; 80(13):1293-1308. PubMed ID: 32691292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding.
    Milling TJ; Frontera J
    Am J Manag Care; 2017 Apr; 23(4 Suppl):S67-S80. PubMed ID: 28581331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we reverse bleeding in patients on direct oral anticoagulants?
    Crowther M; Cuker A
    Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding.
    Little DHW; Sutradhar R; Cerasuolo JO; Perez R; Douketis J; Holbrook A; Paterson JM; Gomes T; Siegal DM
    CMAJ; 2021 Mar; 193(9):E304-E309. PubMed ID: 33649169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant Reversal in Gastrointestinal Bleeding: Review of Treatment Guidelines.
    Milling TJ; Refaai MA; Sengupta N
    Dig Dis Sci; 2021 Nov; 66(11):3698-3714. PubMed ID: 33403486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the perioperative patient on direct oral anticoagulants.
    Leitch J; van Vlymen J
    Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants (DOAC) - Management of emergency situations.
    Lindhoff-Last E
    Hamostaseologie; 2017; 37(4):257-266. PubMed ID: 29582928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
    Desai NR; Cornutt D
    Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.
    Weitz JI
    Semin Respir Crit Care Med; 2017 Feb; 38(1):40-50. PubMed ID: 28208197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Frymire E; Khan S; Johnson AP;
    Thromb Res; 2019 Oct; 182():12-19. PubMed ID: 31434018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents.
    Siegal DM
    J Thromb Thrombolysis; 2015 Apr; 39(3):395-402. PubMed ID: 25586208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.